Alternative Splicing of Endothelial Fibronectin Is Induced by Disturbed Hemodynamics and Protects Against Hemorrhage of the Vessel Wall
暂无分享,去创建一个
[1] M. Schwartz,et al. Flow-dependent cellular mechanotransduction in atherosclerosis , 2013, Journal of Cell Science.
[2] J. Prieto,et al. A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo , 2013, BioMed research international.
[3] M. Malbouyres,et al. CCM1–ICAP-1 complex controls β1 integrin–dependent endothelial contractility and fibronectin remodeling , 2013, The Journal of cell biology.
[4] H. Woo,et al. Physical Factors Effecting Cerebral Aneurysm Pathophysiology , 2013, Annals of Biomedical Engineering.
[5] C. Burge,et al. Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues , 2012, Science.
[6] Shu-xuan Jin,et al. Endogenous Renovascular Hypertension Combined With Low Shear Stress Induces Plaque Rupture in Apolipoprotein E–Deficient Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[7] O. Soehnlein,et al. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation , 2012, EMBO molecular medicine.
[8] D. Boettiger,et al. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts. , 2012, Gastroenterology.
[9] R. Hynes. The evolution of metazoan extracellular matrix , 2012, The Journal of cell biology.
[10] Auinash Kalsotra,et al. Functional consequences of developmentally regulated alternative splicing , 2011, Nature Reviews Genetics.
[11] S. Forbes,et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. , 2011, American journal of respiratory and critical care medicine.
[12] H. Björkbacka,et al. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis. , 2011, Cardiovascular research.
[13] A. Didangelos,et al. Extracellular Matrix Composition and Remodeling in Human Abdominal Aortic Aneurysms: A Proteomics Approach* , 2011, Molecular & Cellular Proteomics.
[14] H. Dietz,et al. Lessons on the pathogenesis of aneurysm from heritable conditions , 2011, Nature.
[15] S. Kurtovic,et al. Impaired Splicing of Fibronectin Is Associated With Thoracic Aortic Aneurysm Formation in Patients With Bicuspid Aortic Valve , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[16] P. Kaufmann,et al. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies. , 2011, Atherosclerosis.
[17] M. Lawton,et al. Critical Roles of Macrophages in the Formation of Intracranial Aneurysm , 2011, Stroke.
[18] J. Mocco,et al. Hemodynamic–Morphologic Discriminants for Intracranial Aneurysm Rupture , 2011, Stroke.
[19] D. Grall,et al. Autocrine fibronectin directs matrix assembly and crosstalk between cell–matrix and cell–cell adhesion in vascular endothelial cells , 2010, Journal of Cell Science.
[20] E. Wang,et al. Analysis and design of RNA sequencing experiments for identifying isoform regulation , 2010, Nature Methods.
[21] J. Schwarzbauer,et al. Assembly of fibronectin extracellular matrix. , 2010, Annual review of cell and developmental biology.
[22] D. Giddens,et al. A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium. , 2010, Journal of visualized experiments : JoVE.
[23] B. Gelfand,et al. Atheroprone Hemodynamics Regulate Fibronectin Deposition to Create Positive Feedback That Sustains Endothelial Inflammation , 2010, Circulation research.
[24] W. Schievink,et al. Screening for intracranial aneurysms in patients with bicuspid aortic valve , 2010, Neurology.
[25] A. Barberis,et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis , 2010, Nature.
[26] D. Milewicz,et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. , 2009, The Journal of clinical investigation.
[27] Richard O. Hynes,et al. The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.
[28] David Harrison,et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. , 2009, American journal of physiology. Heart and circulatory physiology.
[29] V. Korshunov,et al. Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[30] Sophie Astrof,et al. Fibronectins in vascular morphogenesis , 2009, Angiogenesis.
[31] M. Schwartz,et al. The Role of Cellular Adaptation to Mechanical Forces in Atherosclerosis , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[32] Alastair J. Martin,et al. Aneurysm Growth Occurs at Region of Low Wall Shear Stress: Patient-Specific Correlation of Hemodynamics and Growth in a Longitudinal Study , 2008, Stroke.
[33] F. Martinez,et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. , 2008, American journal of respiratory and critical care medicine.
[34] T. Desmettre,et al. COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. , 2007, The New England journal of medicine.
[35] A. Chauhan,et al. Prothrombotic Effects of Fibronectin Isoforms Containing the EDA Domain , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[36] R. Hynes,et al. Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. , 2007, Developmental biology.
[37] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[38] R. Hynes. Cell–matrix adhesion in vascular development , 2007, Journal of thrombosis and haemostasis : JTH.
[39] T. Jacks,et al. Restoration of p53 function leads to tumour regression in vivo , 2007, Nature.
[40] Aloke V. Finn,et al. Atherosclerotic Plaque Progression and Vulnerability to Rupture: Angiogenesis as a Source of Intraplaque Hemorrhage , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[41] P. Heutink,et al. Mutations in Col4a1 Cause Perinatal Cerebral Hemorrhage and Porencephaly , 2005, Science.
[42] M. Schwartz,et al. The subendothelial extracellular matrix modulates NF-κB activation by flow , 2005, The Journal of cell biology.
[43] S. Forbes,et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.
[44] Marko Kangasniemi,et al. Remodeling of Saccular Cerebral Artery Aneurysm Wall Is Associated With Rupture: Histological Analysis of 24 Unruptured and 42 Ruptured Cases , 2004, Stroke.
[45] B. Berk,et al. Strain-Dependent Vascular Remodeling: The “Glagov Phenomenon” Is Genetically Determined , 2004, Circulation.
[46] J. Peters,et al. Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. , 2004, Blood.
[47] Alan Daugherty,et al. Mouse Models of Abdominal Aortic Aneurysms , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[48] B. Berk,et al. Flow-Induced Vascular Remodeling in the Mouse: A Model for Carotid Intima-Media Thickening , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[49] R. Hammer,et al. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[50] H Yonas,et al. Molecular Anatomy of an Intracranial Aneurysm: Coordinated Expression of Genes Involved in Wound Healing and Tissue Remodeling , 2001, Stroke.
[51] Kamin J. Johnson,et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. , 2001, Nature Medicine.
[52] A Daugherty,et al. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.
[53] V. Koteliansky,et al. In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[54] K. Sekiguchi,et al. Alternatively Spliced EDA Segment Regulates Fibronectin-dependent Cell Cycle Progression and Mitogenic Signal Transduction* , 1999, The Journal of Biological Chemistry.
[55] K. Kent,et al. Balloon catheterization induced arterial expression of embryonic fibronectins. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[56] D. Rockey,et al. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis , 1994, The Journal of cell biology.
[57] N. Van Rooijen,et al. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.
[58] B L Langille,et al. Monocyte adhesion and changes in endothelial cell number, morphology, and F-actin distribution elicited by low shear stress in vivo. , 1993, The American journal of pathology.
[59] V. Koteliansky,et al. Expression of extra domain A fibronectin sequence in vascular smooth muscle cells is phenotype dependent , 1989, The Journal of cell biology.
[60] M. Schwartz,et al. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. , 2005, The Journal of cell biology.